Disease / Etiology
|
Preferred
|
Alternative
|
Comments
|
Melioidosis:
Burkholderia pseudomallei |
Initial:
Without Complication
Ceftazidime 2 gm IV q6H
±
* Co-trimoxazole 480 mg tablets / 480 mg ampoules;
>60 kg
4 tablets PO q12H
/ 4 amps IV q12H
40 - 60 kg
3 tablets PO q12H
/ 3 amps IV q12H
<40 kg
2 tablets PO q12H
/ 2 amps IV q12H
Neuromelioidosis or Persistent Bacteraemia or In ICU or Treatment Failure
Meropenem 1 gm IV q8H
±
* Co-trimoxazole 480 mg tablets / 480 mg ampoules;
>60 kg
4 tablets PO q12H
/ 4 amps IV q12H
40 - 60 kg
3 tablets PO q12H
/ 3 amps IV q12H
<40 kg
2 tablets PO q12H
/ 2 amps IV q12H
|
|
Modify treatment according to culture & sensitivity.
Abscesses should be surgically drained.
Ceftazidime 6 gm / day can be given by continuous infusion after a 2 gm bolus.
After
loading dose of 2g, Ceftazidime 8 gm / day can be given by continuous infusion.
Duration: 10 - 14 days.
4 - 8 weeks IV needed if severe disease (i.e. septic shock, deep seated abscess
or organ abscesses, extensive lung disease, osteomyelitis, septic arthritis or
neurological Melioidosis)
4 weeks:
Septic joint, deep seated abscess or
organ abscesses, extensive lung disease
6 weeks:
Osteomyelitis
8 weeks:
Neurological melioidosis
* Consider adding Co-trimoxazole for patients with severe infection involving
the brain, prostate or other privileged site- brain, eyes, testicular,
articulart cartilage (same dosing as described for eradication therapy).
Co-trimoxazole may be given IVI over 30 minutes 12 hourly, or nasogastric, or
oral suspension.
**Meropenem 2gm IV q8H for infection with
Central nervous system disease |
Oral Eradication Phase Therapy:
Co-trimoxazole 480 mg tablets
>60 kg
4 tablets PO q12H
40 - 60 kg
3 tablets PO q12H
<40 kg
2 tablets PO q12H
|
** Co-amoxiclav 625 mg tablets
>60 kg
3 tablets PO q8H
< 60 kg
2 tablets PO q8H
|
Duration: Minimum 12 weeks
OM and neurological 6 months.
** Only use if resistant or allergic to Co-Trimoxazole
|
Rickettsia:
Scrub, Murine & Endemic Typhus
Uncomplicated
Complicated |
Doxycycline 100 mg PO q12H for 7 - 10
days
Azithromycin 500 mg PO / IV q24H for 5 days |
Azithromycin 500mg PO/IV x 1 dose |
*To use Azithromycin in pregnancy |
Enteric / Typhoid Fever:
S. typhi
S. paratyphi A / B / C |
Ceftriaxone
2gm IV q24H until improve clinically then convert to oral
Once
culture available, to target antibiotics according to sensitivities
If sensitive, for
Ciprofloxacin 400 mg IV q12H for 7 - 14 days (switch to PO 500 mg q12H as soon
as possible)
|
|
If septic shock or severely
ill use Dexamethasone 3 mg/kg then 1 mg/kg qid x 8 doses a few minutes before
antibiotic.
If acquired from indian sub-continent or SE Asia (Indonesia, Thailand,
Myanmar), to confirm Fluoroquinolone susceptibility with lab. |
Non-Typhoid Bacteremia:
Salmonella sp |
Ceftriaxone
2 gm IV q24H till improve clinically then convert to oral
Once
culture available, to target antibiotics according to sensitivities
If
sensitive, for Ciprofloxacin 400 mg IV q12H for 7 - 14 days* (switch to PO 500
mg q12H as soon as possible)s
|
Co-trimoxazole
(Trimethoprim component) 8 - 10 mg/kg/day divided q8H (Once
sensitivities available and if patient allergic to beta lactams) |
Look for dissemination (mycotic
aneurysm, OM etc).
*Duration:
No
extra-intestinal infection: 14 days
Extra-intestinal infection
(Mycotic aneurysm, osteomyelitis, or immunosuppressed): 4 – 6 weeks |
Leptospirosis:
L. icterohaemorrhagiae
L. canicola |
Mild/ Outpatient:
Doxycyline 100 mg PO q12H for 5-7
days |
Mild: Amoxicillin 500mg PO q8H
for 7 days
OR
Azithromycin 1 gm IV / PO q24H D1, then 500 mg IV / PO q24H D2 and D3 |
Mild diseases are self
limiting and does not require treatment.
Jarisch-Herxheimer reaction can occur post penicillin.
Severe: Leptospiral pulmonary syndrome, multiorgan involvement, sepsis |
Severe:
Penicillin 1.5 MU q6H IV for 7 days
|
Severe:
Ceftriaxone 2 gm q24H IV for 7 days
|
Brucellosis:
B abortus (cow)
B suis (swine)
B melitensis (goats)
B canis (dogs) |
Systemic disease:
Doxycycline 100 mg PO q12H for 6 weeks
+
Gentamicin 4 - 6 mg/kg IV q24H (monitor TDM) for 1 week
Spondyllitis, Sacroilitis
Doxycycline 100 mg PO q12H for 3 months
+
Gentamicin 5 mg/kg IV q24H (monitor TDM) for 1 week
+
Rifampicin 600 - 900 mg PO q24H for 3 months
Neurobrucelosis
Doxycycline 100 mg PO q12H
+
Rifampicin 600 - 900 mg PO q24H
+
Ceftriaxone 2 gm IV q12H until CSF normal
Endocarditis
Surgery
+
Doxycycline 100 mg PO q12H for 6 weeks to 6 months
+
Rifampicin 600 mg PO q24H for 6 weeks to 6 months
+
Co-trimoxazole (Trimethoprim component) 5 mg/kg PO q12H for 6 weeks to 6 months
+
Gentamicin 5 mg/kg IV q24H for 2 - 4 weeks
|
Doxycycline 100 mg PO q12H
OR Co-trimoxazole (Trimethoprim component) 5 mg/kg PO q12H
+
Rifampicin 600 mg PO q24h
For 6 weeks
Ciprofloxacin 750 mg PO q12H
+
Rifampicin 600 - 900 mg q24H
For 3 months
Doxycycline 100 mg PO q12H
+
Rifampicin 600 - 900 mg PO q24H
+
Co-trimoxazole (Trimethoprim component) 5 mg/kg PO q12H in divided dose until CSF normal |
Relapse rate 10%
Bone involvement 20 - 30%
Neurobricellosis 1%
Steroids not recommended.
Endocarditis rare, but highest mortality: needs surgery
Pregnancy:
Rifampicin 600-900mg (15mg/kg) PO q24H for 6 weeks
+
Co-trimoxazole 480mg tab (2
tabs) q12H for 6 weeks
Ciprofloxacin: active in vitro but clinical response not good.
Clinical response to
Cetriaxone is variable.
Duration: Until CSF clears
|
Cat scratch disease & other bartonella infections
|
Extensive Lmphadenopathy / Systemic Disease
Azithromycin 500 mg PO D1 then 250 mg PO q24H for 4 days
Endocarditis
Surgery
+
Doxycycline 100 mg PO q12H for 6 weeks
+
Gentamicin 1 mg/kg IV q8H for 2 weeks (monitor TDM)
OR Rifampicin 300 mg q12H for 2 weeks
|
Doxycycline 100mg q12H for 14 days
Surgery
+
Azithromycin 500 mg PO q24H for 3 months
+
Gentamicin 1 mg/kg IV q8H for 2 weeks (monitor TDM)
OR Rifampicin 300 mg q12H for 2 weeks
|
Duration:
If valve not removed,
Regimen with Doxycycline is to be continued for 3 months.
Regimen with Azithromycin is to be continued for 6 months. |
Cholera |
HYDRATION is primary therapy
* Doxycycline 300mg PO single dose |
** Erythromycin Ethyl Succinate 400 mg PO q8H for 3 days
OR
Azithromycin 1 gm PO single dose
|
* Non Tetracycline resistance.
** Tetracycline resistance and pregnancy: Erythromycin Ethyl Succinate or Azithromycin. |
Tetanus Clostridium Tetani |
Surgical debridement of infected
source tissueMetronidazole 1000 mg IV q12H
OR
Benzylpenicillin 3 MU IV q4H
+
Human Tetanus Immunoglobulin 3000 iu to 6000 IU IM single dose
|
Doxycycline 100 mg PO q12H
OR
Clindamycin 600 mg IV q6H
|
Duration: 7 - 10 days
Penicillin, a GABA antagonist, may aggravate the spasms.
Initiate a full course of tetanus vaccination. |
Malaria (Falciparum, Vivax, Ovale, Knowlesi, Malariae)
|
Complicated Malaria |
D1: Artesunate 2.4 mg/kg IV stat then 2.4 mg/kg at 12 hours
D2: Artesunate 2.4 mg/kg IV q24H till oral conversion
(* Parenteral Artesunate should be given for a minimum of 24 hours)
+
Primaquine# 30 mg PO single dose (for P. falciparum), 15 - 30 mg q24H for 14 days (for P. vivax / ovale)
Switch to oral Riamet®## when possible
|
Artesunate
200mg/Mefloquine* 440mg q24H for 3 days
Or
Oral
Quinine* (10mg/kg) q8H for 7 days +
Doxycycline
100mg q12H for 7 days |
WHO recommended combination therapy.
#Primaquine (dosed as base): check G6PD status before use.
45 mg/week x 8 weeks for G6PD deficient patients.
Contraindicated in pregnant women, children aged < 6 months, women BF child < 6 months.
##Riamet®: Artemether 20 mg / Lumefantrine 120 mg
Adult (> 35 kg)
D1: 4 tablets stat then 4 tablets at 8 hours
D2 to D3: 4 tablets q12H
Total: 24 tablets
Adult (< 35 kg)
D1: 3 tablets stat then 3 tablets at 8 hours
D2 to D3: 3 tablets q12H
Total: 18 tablets
Pregnancy: Avoid Doxycycline and Primaquine. Relative contraindication of Artemisinin in 1st trimester.
Seek expert advice.
*Artesunate 200mg/Mefloquine 440mg and oral Quinine
are not available at UMMC
|
Plasmodium Falciparum - Uncomplicated |
Riamet®##
+
Primaquine# 30 mg PO single dose
|
Plasmodium Vivax or Ovale - Uncomplicated |
Riamet®##
+
Primaquine# 15 - 30 mg PO q24H for 14 days
|
|
|
Plasmodium Knowlesi - Uncomplicated |
Riamet®##
|
|
|
Mixed Malaria Infection |
Treat as Plasmodium Falciparum
|
|
|